Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded Last action
- Contract number
- SPE2DR26FU8YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,557
Award facts
- Contract value 100% obligated
- $11,557.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,557.40 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for moxifloxacin HCL 400 mg tablets, UD 50s, with an ultimate completion date of March 6, 2026.
The order is issued under a firm fixed-price structure with no set-aside. Place of performance is Conshohocken, PA. The order carries no set-aside designation and was competitively awarded.
Quick answers
Who was awarded contract SPE2DR26FU8YU?
SPE2DR26FU8YU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 5, 2026.
How much is contract SPE2DR26FU8YU worth?
The government has obligated $11,557 on SPE2DR26FU8YU.
Is contract SPE2DR26FU8YU an order under another contract?
Yes. SPE2DR26FU8YU is a delivery order under SPE2DR25D3112, an indefinite delivery contract.
Was contract SPE2DR26FU8YU competed?
The extent of competition for SPE2DR26FU8YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award